Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modifications of Klotho expression in kidney diseases
Jinkun Xia, Wangsen Cao
Journal of Molecular Medicine (2021) Vol. 99, Iss. 5, pp. 581-592
Closed Access | Times Cited: 22

Showing 22 citing articles:

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
Shanshan Li, Qian Sun, Meng-Ru Hua, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 61
PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond
Ignacio Portales‐Castillo, Petra Šimić
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 42
The controversy of klotho as a potential biomarker in chronic kidney disease
Lixia Yu, Shasha Li, Min-Yue Sha, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale, Vishwadeep Shelke, Himanshu Sankrityayan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166532-166532
Open Access | Times Cited: 21
Lactoferrin alleviates cyclophosphamide induced-nephropathy through suppressing the orchestration between Wnt4/β-catenin and ERK1/2/NF-κB signaling and modulating klotho and Nrf2/HO-1 pathway
Ola S. Mohamed, Nayira A. Abdel Baky, Mohamed M. Sayed‐Ahmed, et al.
Life Sciences (2023) Vol. 319, pp. 121528-121528
Closed Access | Times Cited: 11
SHANK1 facilitates non-small cell lung cancer processes through modulating the ubiquitination of Klotho by interacting with MDM2
Bo Chen, Hongye Zhao, Min Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 16
Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity
Ajinath Kale, Himanshu Sankrityayan, Anil Bhanudas Gaikwad
Life Sciences (2021) Vol. 288, pp. 120194-120194
Closed Access | Times Cited: 19
Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases
Lijun Zhang, Wangsen Cao
Journal of Molecular Medicine (2021) Vol. 100, Iss. 1, pp. 43-51
Closed Access | Times Cited: 17
Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice
Fengchen Shen, Xiying Hou, Tingting Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Comparative Analysis of Acute Kidney Injury Models and Related Fibrogenic Responses: Convergence on Methylation Patterns Regulated by Cold Shock Protein
Sabine Brandt, Anja Bernhardt, Saskia Häberer, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 367-367
Open Access | Times Cited: 2
Histone deacetylases and inhibitors in diabetes mellitus and its complications
Wang Li, Yuning Bai, Zhengmin Cao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117010-117010
Open Access | Times Cited: 2
Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Min Liu, Y Zhang, Ping Zhan, et al.
Pharmacological Research (2023) Vol. 198, pp. 107009-107009
Open Access | Times Cited: 6
Urinary Excretion of Biomolecules Related to Cell Cycle, Proliferation, and Autophagy in Subjects with Type 2 Diabetes and Chronic Kidney Disease
Anton I. Korbut, V. V. Romanov, Vadim V. Klimontov
Biomedicines (2024) Vol. 12, Iss. 3, pp. 487-487
Open Access | Times Cited: 1
Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins
Tathambika Tejeswini Sen, Ajinath Kale, Maciej Lech, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103466-103466
Closed Access | Times Cited: 6
Renal Function Mediates the Association Between Klotho and Congestive Heart Failure Among Middle-Aged and Older Individuals
Xu Zhu, Xinyi Lu, Ting Yin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease
Yoshiyasu Ogura, Imari Mimura
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 3
CCL5 Suppresses Klotho Expression via p-STAT3/DNA Methyltransferase1-Mediated Promoter Hypermethylation
Qifeng Liu, Shasha Li, Lixia Yu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 5
Low-dose 5-aza-2′-deoxycytidine protects against early renal injury by increasing klotho expression
Yanlong Zhao, Xiaorong Zeng, Xinli Xu, et al.
Epigenomics (2022) Vol. 14, Iss. 22, pp. 1411-1425
Closed Access | Times Cited: 4
Association of serum klotho level with albuminuria in middle‑aged and elderly participants without diabetes mellitus: a cross‑sectional study
Dawei Chen, Mengxing Chen, Zhongquan Qi, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Nonlinear relationship between serum Klotho and chronic kidney disease in US adults with metabolic syndrome
Xiaobin Lin, Lin Yang
Frontiers in Endocrinology (2024) Vol. 15
Open Access
piRNAs and miRNAs Can Bind to mRNA of <i>KLOTHO</i> and <i>FGF23</i> Genes
Ivashchenko At, Kyrmyzy Akhmetova, Murat Zhanuzakov, et al.
(2023)
Open Access | Times Cited: 1
Klotho alleviates vancomycin-induced acute kidney injury by upregulating anti-oxidative capacity via JAK2/STAT3/GPx3 axis
Meng Meng Wang, Yue Zhou, Rui Yin, et al.
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top